RT Journal Article
SR Electronic
T1 Acute kidney injury in hospitalized patients due to COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.31.21257656
DO 10.1101/2021.05.31.21257656
A1 Pehuén Fernández
A1 Emanuel José Saad
A1 Augusto Douthat
A1 Federico Ariel Marucco
A1 María Celeste Heredia
A1 Ayelén Tarditi Barra
A1 Silvina Trinidad Rodriguez Bonazzi
A1 Melani Zlotogora
A1 María Antonella Correa Barovero
A1 Sofía Villada
A1 Juan Pablo Maldonado
A1 Juan Pablo Caeiro
A1 Ricardo Arturo Albertini
A1 Jorge De La Fuente
A1 Walter Guillermo Douthat
YR 2021
UL http://medrxiv.org/content/early/2021/06/01/2021.05.31.21257656.abstract
AB The incidence of acute kidney injury (AKI) in hospitalized patients with coronavirus disease 2019 (COVID-19) is variable, being associated with worse outcomes. The objectives of the study were to evaluate the incidence, risk factors and impact of AKI in subjects hospitalized for COVID-19 in two third- level hospitals in Córdoba, Argentina.A retrospective cohort study was conducted. 448 adults who were consecutively hospitalized for COVID-19 between March and the end of October 2020 at Hospital Privado Universitario de Córdoba and Hospital Raúl Angel Ferreyra were included. The incidence of AKI was 19% (n = 85). 50.6% presented AKI stage 1 (n=43), 20% stage 2 (n=17) and 29.4% stage 3 (n=25, of which 18 required renal replacement therapy). In the multivariate analysis, the variables that were independently associated with AKI were: age (adjusted Odd ratio -aOR- =1.30, 95%CI=1.04-1.63, p=0.022), history of chronic kidney disease (aOR=9.92, 95%CI=4.52-21.77, p<0.001), blood neutrophil count at admission (aOR=1.09, 95%CI=1.01-1.18, p=0.037) and requirement for mechanical ventilation (MV) (aOR=6.69, 95%CI=2.24-19.9, p=0.001). AKI was associated with longer hospitalization, greater admission and length of stay in the intensive care unit, a positive association with bacterial superinfection, sepsis, respiratory distress syndrome, MV requirement and mortality (mortality with AKI=47.1% vs without AKI=12.4%, p<0.001). AKI was independently associated with higher mortality (aOR=3.32, 95%CI=1.6-6.9, p=0.001).In conclusion, the incidence of AKI in adults hospitalized for COVID-19 was 19% and had a clear impact on morbidity and mortality. Local predisposing factors for AKI were identified.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical oversight was waived by the Institutional Committee of Ethics in Health Research (C.I.E.I.S) of the Hospital Privado Universitario de Cordoba (Cordoba, Argentina) given the observational characteristic of the study and the de-identified of the data. The study was reviewed and approved by the research committee of the Hospital Privado Universitario de Cordoba, Argentina.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data was deidentified by the investigator and is restricted to use by authorized individuals. The deidentified dataset is not publicly available.